FMCXF(FMCXF)
FMCXF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $295M | $453M | $594M | $680M |
| Low | $295M | $453M | $594M | $680M |
| High | $295M | $453M | $594M | $680M |
| EBITDA Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EBIT Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Net Income Avg | $39M | $28M | $104M | $145M |
| Low | $39M | $28M | $104M | $145M |
| High | $39M | $28M | $104M | $145M |
| EPS Avg | $0.08 | $0.06 | $0.21 | $0.29 |
| Low | $0.08 | $0.06 | $0.21 | $0.29 |
| High | $0.08 | $0.06 | $0.21 | $0.29 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $117M | $155M | $136M | $133M | $135M | $133M | $122M | $118M |
| Low | $117M | $155M | $136M | $133M | $135M | $133M | $122M | $118M |
| High | $117M | $155M | $136M | $133M | $135M | $133M | $122M | $118M |
| EBITDA Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Net Income Avg | $47M | $44M | $47M | $45M | $46M | $46M | — | — |
| Low | $47M | $44M | $47M | $45M | $46M | $46M | — | — |
| High | $47M | $44M | $47M | $45M | $46M | $46M | — | — |
| EPS Avg | $0.09 | $0.08 | $0.09 | $0.08 | $0.08 | $0.08 | — | — |
| Low | $0.09 | $0.08 | $0.09 | $0.08 | $0.08 | $0.08 | — | — |
| High | $0.09 | $0.08 | $0.09 | $0.08 | $0.08 | $0.08 | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — |